Sign In
Buy RDY
$13.02
-0.0100 (-0.0767%)
At Close: Jun 03, 2026
5 Growth Opportunities Thriving on Relative Price Strength
09:34am, Friday, 18'th Aug 2023
HURN, EHC, RDY, BOOM and HWKN are five stocks with explosive relative price strength.
Add These 4 Top-Performing Liquid Stocks for Strong Returns
08:49am, Friday, 18'th Aug 2023
Here are four top-ranked liquid stocks, Dr. Reddy's (RDY), Surmodics (SRDX), Fluor Corporation (FLR) and GigaCloud Technology (GCT), which investors can add to their portfolio for solid gains.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
12:17pm, Friday, 11'th Aug 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to AMPH, RDY and TEVA.
Buy These 4 Low-Beta Stocks to Counter the Choppy Market
09:58am, Wednesday, 09'th Aug 2023
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Trip.com (TCOM), Dr. Reddy's (RDY), Sterling Check (STER) and MINISO Group (MNSO) are poised to gain.
Dr. Reddy's (RDY) Q1 Earnings and Revenues Beat Estimates
09:30am, Friday, 28'th Jul 2023
Dr. Reddy's (RDY) reports better-than-expected fiscal first-quarter 2024 results.
Dr. Reddy's Laboratories: Unpacking The Critical Factors, Reiterate Buy
07:34am, Wednesday, 07'th Jun 2023
Dr. Reddy's Laboratories Ltd. (RDY) remains an attractive investment due to its strong Q4 and FY'23 numbers, exposure to the Indian generics market, and consistent new product launches. RDY is well-po
Dr. Reddy's (RDY) Meets Goals in Actemra Biosimilar Study
07:59am, Tuesday, 06'th Jun 2023
Dr. Reddy's (RDY) announces meeting primary and secondary endpoints in the phase I study of its proposed tocilizumab biosimilar for the treatment of rheumatoid arthritis in adults.
The 3 Most Undervalued Value Stocks to Buy in June 2023
03:51pm, Sunday, 04'th Jun 2023
With the market facing myriad pressure points – predominantly stubbornly high inflation along with general anxieties about an incoming recession – the bright side is that investors have options re
3 Generic Drug Stocks to Watch Amid Macro Headwinds
09:08am, Tuesday, 23'rd May 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
11:25am, Thursday, 11'th May 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Dr Reddy's Laboratories Ltd (RDY) Q4 2023 Earnings Call Transcript
02:28am, Thursday, 11'th May 2023
Dr Reddy's Laboratories Ltd (NYSE:RDY ) Q4 2023 Earnings Conference Call May 10, 2023 10:00 AM ET Company Participants Richa Periwal - IR Gunupati Prasad - Co-Chairman Parag Agarwal - CFO Erez Israeli
Dr. Reddy's: A Profitable, Predictable Margin Expander
12:29pm, Monday, 08'th May 2023
The Profitable Predictable Margin Expanders screener on GuruFocus has been a helpful one for me when searching for quality stocks that show solid growth. It does what the name suggests - it sorts thro
U.S. Economy Suffering From Dichotomy: 5 Safe Stocks
10:37am, Thursday, 13'th Apr 2023
We have selected five defensive stocks with strong momentum. These are: CAG, COTY, NEE, NJR, RDY.
COYA, Dr. Reddy's Sign Deal for Proposed Abatacept Biosimilar
01:00pm, Tuesday, 21'st Mar 2023
COYA and Dr. Reddy's enter into a license agreement where the latter will source proposed biosimilar of abatacept biosimilar to Coya to develop and commercialize COYA 302.
5 Top-Ranked Dividend Stocks to Counter Market Volatility
06:09am, Tuesday, 21'st Mar 2023
Dr. Reddys (RDY), Darden Restaurants (DRI), Interpublic Group (IPG), Microchip Technology (MCHP) and Valero Energy (VLO) could be compelling picks amid market volatility.
